menu ☰
menu ˟

Romosozumab increased BMD, bone formation in postmenopausal women

02 Jan 2014
Romosozumab was associated with increased bone mineral density and bone formation and with decreased bone resorption in postmenopausal women with low bone mass, according to results from a 1-year phase 2 study.All dosages of romosozumab (AMG 785/CDP7...

Click here to view the full article which appeared in Orthopedics

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.